ロード中...
COVID-19 vaccine trials: The use of active controls and non-inferiority studies
BACKGROUND: Recently emerging results from a few placebo-controlled randomized trials of COVID-19 vaccines revealed estimates of 62%–95% relative reductions in risk of virologically confirmed symptomatic COVID-19 disease, over approximately 2-month average follow-up period. Additional safe and effec...
保存先:
| 出版年: | Clin Trials |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8172418/ https://ncbi.nlm.nih.gov/pubmed/33535811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774520988244 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|